Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence diagnosis and photodynamic therapy in psoriasis and skin premalignancies
2006-003981-33Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 5-aminolevulinic acid in psoriasis, cutaneous malignancy and cutaneous lesion, sponsored by Radboud University Medical Center. Primary endpoints: Fluorescence characteristics after ALA-based fluorescence diagnosis and Improvement of photodynamic therapy treatment results. Started Aug 2006; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
psoriasiscutaneous malignancycutaneous lesion
Beyond the preview
Go deeper on 2006-003981-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003981-33.